The OncoMiD® series of culture media have been optimised to allow the preservation of dissociated tumour cells from human samples in primary culture. With a known and standardised composition, and not containing foetal calf serum, they have been formulated specifically for the ex vivo culture of tumour cells from human cancer samples. They allow the selection of cells of tumour epithelial origin over cells of the microenvironment and are suitable for all tumour subtypes. OncoMiD® specific media have been developed for tumour culture from:

•  Breast tumours

	Cat#	Description	Cond.
	250 OMCULT2-Breast	OncoMiD for breast medium for culture of breast primary cultures	1bottle
	OMKIT1-Breast	OncoMid-Kit for Transport, Dissociation and Culture of Breast Cancer Cells from Tumor	Kit

• Colon/rectum tumours

	Cat#	Description	Cond.
	250 OMCULT2	OncoMiD for colon medium for culture of colon tumour primary cultures	1bottle
	OMKIT1	OncoMid-Kit for Transport, Dissociation and Culture of Colorectal Cancer Cells from Tumor	Kit

• Glyoblastoma tumours

	Cat#	Description	Cond.
	250 OMCULT2-Glyoblastoma	OncoMiD for Glyoblastoma medium for culture of Glyoblastoma primary cultures	1bottle

• Ovarian tumours

	Cat#	Description	Cond.
	250 OMCULT2-Ovary	OncoMiD for Ovary medium for culture of Ovary primary cultures	1bottle
	OMKIT1-Ovary	OncoMid-Kit for Transport, Dissociation and Culture of ovary Cancer Cells from Tumor	Kit

The OncoMiD® defined culture media have been optimised in order to obtain, one week after dissociation and for all cancer subtypes of the pathology to be treated, a purified primary culture of tumour cells. During these 7 days, the high cell death observed reflects the selective elimination of cells from the microenvironment. The procedure is optimal when all media OncoMiD-Via® (ref. OMVIA1/2/3), OncoMiD-Diss® (ref. OMDIS1/2/3) and OncoMid® (ref. OMCULT1/2/3) are combined.

Storage: 2-8°C

For Reasearch Use Only 

For profit organization / Corporations, please contact tech@biovalley.fr for quotation